Article Details

Hikma Pharmaceuticals (LON:HIK) “Buy” Rating Reaffirmed by Analysts at numis; With GBX ...

Retrieved on: 2017-12-19 21:52:30

Tags for this article:

Click the tags to see associated articles and topics

Hikma Pharmaceuticals (LON:HIK) “Buy” Rating Reaffirmed by Analysts at numis; With GBX .... View article details on hiswai:

Excerpt

<div>$3.99 million worth of <b>Intel</b> Corporation (NASDAQ:INTC) was sold by BRYANT ANDY D. 1,424 shares valued at $51,834 were sold by RENDUCHINTALA VENKATA S M on Monday, August 7. YOFFIE DAVID B had sold 30,000 shares worth $1.35 million on Monday, October 30. <b>Krzanich Brian</b> M sold ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up